Kos Biotechnology Partners Invests In Golden Age Health To Expand Rare Disease Access Across Asia
· pulse2.com · popularity 19/100 · 0 similar stories today · Chronic Conditions (Health & Life Sciences)
Read the original at pulse2.com →
Summary
Kos Biotechnology Partners has made a strategic investment in Golden Age Health through its inaugural Kos BioVentures fund, supporting the specialty pharmaceutical company’s expansion across Greater China and the Asia-Pacific region. The post Kos Biotechnology Partners Invests In Golden Age Health To Expand Rare Disease Access Across Asia appeared first on Pulse 2.0 .
Found in: Pulse 2.0. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 7.